Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1985
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180335/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3002246/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.6.815
Oznake:	Označite Brez oznak, prvi označite!